Bayer
A strategic partnership leveraging Ginkgo's massive synthetic biology foundries to develop next-generation agricultural biologicals, commercialized through Bayer's extensive distribution network.
- Country
- Germany
Enterprise
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| agri-tech-precision | ✓ | ✓ | — | ✓ |
| crop-biotech | ✓ | ✓ | ✓ | ✓ |
| finance-investment | ✓ | ✓ | — | ✓ |
Regulatorsfdaemanmpaepaefsamoa-chinausda-aphis
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Agroecology & regenerative farming | agri-tech-precision | Low | → |
| Corporate biotech accelerators (JLABS, Bayer CoLaborator) | finance-investment | Medium | → |
| Nitrogen-fixing microbial inoculants | crop-biotech | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.